Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KOUNO-TORI: KW-3357 in Early Onset Severe Preeclampsia
NCT04182373Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Nov 2019
- Primary completion
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin gamma in preeclampsia, sponsored by Kyowa Kirin. Started Nov 2019; status: completed.
02
Drugs
antithrombin gamma
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT04182373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04182373.